Screening Of Adult urBan pOpulation To diAgnose Heart Failure
NCT ID: NCT03526601
Last Updated: 2018-05-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
2861 participants
OBSERVATIONAL
2017-05-10
2018-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Early Diagnosis of Heart Failure Using NT-proBNP Levels in Primary Care
NCT07059260
A Prospective Evaluation of Natriuretic Peptide Based Referral of CHF Patients in Primary Care
NCT02807857
A Health Economic Evaluation of Using N-Terminal Pro Brain Natriuretic Peptide (NT-Pro BNP) in Acute Heart Failure
NCT03669198
Screening for Heart Failure in General Medicine Consultations
NCT06865053
Exploration of Dyspnea at Non-high Brain Natriuretic Peptide (BNP)
NCT03550235
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
NT-proBNP, echocardiography
screening
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* living in Murska Sobota
* part of representative sample as selected by Statistical Office of the Republic of Slovenia
Exclusion Criteria
55 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Roche Pharma AG
INDUSTRY
Slovenian Research Agency
OTHER
Murska Sobota Municipiality
UNKNOWN
Community Health Center Murska Sobota
UNKNOWN
General Hospital Murska Sobota
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mitja Lainscak
Professor of Internal Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mitja Lainscak, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
General Hospital Murska Sobota
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
General Hospital Murska Sobota
Murska Sobota, , Slovenia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SBMS001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.